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Abbreviation List 
ATS (American Thoracic Society) 
BMI (body mass index) 
CDC (Centers for Disease Control and Prevention) 
FVC (forced vital capacity) 
FEV1 (forced expiratory volume during the first second) 
FEF 25-75% (forced expiratory flow between 25% and 75% of vital capacity) 
HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) 
IR (insulin resistance) 
IRB (institutional review board) 
NHANES (National Health and Nutrition Examination Survey) 
PFT (pulmonary function test) 
WC (waist circumference) 
WHtR (waist to height ratio) 
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Abstract  
Background: Obesity is considered a risk factor for both asthma and insulin 
resistance in adults. Insulin resistance (IR) also influences the pulmonary function in 
the non-obese population.  
Objective: To investigate the modifying effect of insulin resistance on the predictive 
role of anthropometric measures in the estimation of impaired lung function among 
asthmatic adults. 
Methods: A cross-sectional study of 1276 adults extracted from NHANES 2009-
2012 database was performed. Adjusted multivariate linear regression was 
conducted to analyse the contributory role of obesity and IR in predicting lung 
function among asthmatic adults. 
Results: BMI, waist circumference (WC), and waist to height ratio (WHtR) showed 
significantly negative correlations with FVC (r=--0.24, -0.18, -0.39, respectively; 
p<0.001), FEV1(r=--0.24, -0.21, -0.40, respectively; p<0.001), and FEF 25-75% (r=--
0.15, -0.18, -0.27, respectively; p<0.001). Even after adjustment for the covariates 
(age, gender, smoking history, and standing height), BMI and HOMA-IR had 
significant relationships with FVC ((β=-10.3; p<0.01) and (β=-16.0; p<0.05)) and 
FEV1((β=-8.7; p<0.01) and (β=-11.7; p<0.05)). BMI could significantly predict the 
decreased FVC (β=-13.7; p<0.01) and FEV1(β=-10.7; p<0.01) only in the insulin 
resistant asthmatics. 
Conclusion: WHtR and IR predict impaired lung function in overweight/obese 
asthmatic adults independently. IR also modifies the association between excessive 
adiposity and respiratory function in asthmatic adult.  
Keywords: central obesity; asthma; insulin resistance; waist to height ratio; 
pulmonary function 
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Introduction  
Obesity and asthma are two contemporaneous public health concerns of the new 
century. In 2014, at least 600 million individuals 18 years and older were obese 
across the world (WHO 2000). Asthma is also a prevalent condition, affecting more 
than 300 million people worldwide (HSE 2013). There is now compelling evidence to 
suggest a sex and age-dependent contributory role of obesity to the development, 
severity and biological underpinning of asthma. Several observational studies have 
indicated a higher prevalence of asthma within the obese population (Ford, 2005; 
Beuther and Sutherland 2007). In prospective studies, excess adiposity, particularly 
visceral obesity, has been shown to be a risk factor for the development and severity 
of asthma in both adults and children (Mannino et al 2006; Brumpton et al. 2013; 
Capelo et al. 2015; Papoutsakis et al. 2015). The relationship between obesity and 
adult-onset asthma is further supported by weight change studies which show 
improvements in asthma severity and pulmonary function after weight reduction 
(Spivak et al. 2005). Noticeably, obese asthmatics experience more symptoms and 
increased or prolonged exacerbations. (Woolford et al. 2007). This obese-asthma 
phenotype which exhibits Th2-independent neutrophilic airway inflammation may 
involve other contributing elements, including metabolic syndrome (Scott et al. 
2012). The impaired lung function of obese asthmatics could be due, in part, to 
metabolic abnormalities (Mafort et al. 2016). There is a bidirectional link between 
asthma and metabolic syndrome (Del-Rio-Navarro et al. 2010; Rasmussen et al. 
2013). Of relevance, insulin resistance (IR) and the consequent hyperinsulinaemia 
also have strong molecular links with pulmonary disease, especially asthma (Singh 
et al. 2013). Indeed, IR has been reported to be a stronger correlate of asthma than 
any obesity-related anthropometric measures (Husemoen et al. 2007). IR has been 
shown to be inversely related to lung function among overweight or obese 
adolescents (Forno et al 2015). Likewise, IR increases the chance of asthma- like 
symptoms in the adult population (Thomsen et al. 2010). It also strengthens the 
association between current asthma and obesity, independent of other components 
of metabolic syndrome (Cardet 2016). Higher IR has also been reported to be a 
distinguishing factor between asthmatic versus non-asthmatic morbidly obese adults 
(Kim et al. 2014). Although several studies have shown a modifying effect of IR on 
the relationship between obesity and asthma in the paediatric population, very little 
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has been done to elucidate the contributory role of insulin resistance on the 
association of adiposity measures, particularly the waist-to-height ratio (WHtR), with 
the indices of lung function, especially forced vital capacity (FVC), forced expiratory 
volume during the first second (FEV1), and forced expiratory flow between 25% and 
75% of vital capacity (FEF 25-75%) among asthmatic adults. 
 
Aims  
In view of this apparent shortcoming in the asthma-obesity research, this study set 
out to:  
Investigate the modifying effect of insulin resistance on the association between 
obesity and reduced lung function in asthmatic adults. 
and  
to assess the contribution of insulin resistance and visceral adiposity to the functional 
variations of small airways in asthmatic adults. 
 
Methods and study population 
This cross-sectional study pooled 4 years (2009-2012) of NHANES data accessed 
via the Centers for Disease Control and Prevention (CDC) website 
(http://www.cdc.gov/Nchs/Nhanes). Two separate datasets (2009-2010 and 2011-
2012) were chosen to increase the sample size and the power of study. Distinct data 
files were merged into the IBM SPSS statistics data editor software version 23. A 
total of 1276 asthmatic adults (≥18 years) were included in this analysis, with asthma 
being defined as the subject having had asthma diagnosed by a health care 
professional. Wait circumference (WC) and WHtR were selected as measures of 
central adiposity. Based on their BMI, the subjects were divided into two groups: not 
overweight/obese (BMI<25 kg/m2) and overweight/obese (BMI≥25 kg/m2) (WHO 
1995). WHtR > 0.50 was assigned as a cutoff for central obesity (WHO 2008). Insulin 
resistance was assessed by the Homeostasis Model Assessment of IR (HOMA-IR) 
value based on the following formula: 
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HOMA-IR (mmol/l × μU/ml) = (Fasting insulin (µU/ml) × Fasting glucose [mmol/l] 
/22:5) (Wallace et al. 2004) 
Insulin resistance was defined as: HOMA-IR: > 2.5 (Singh et al. 2013) 
Spirometric parameters, recorded in compliance with the American Thoracic Society 
(ATS) recommendations (Miller 2005), were FVC, FEV1, FEV1/FVC (Swanney et al. 
2008) and FEF25-75% (Tavakol et al. 2013). (add section on sample weight).  
To account for the complex sampling design of NHANES, corresponding sample 
weights were included in the statistical methods according to instructions provided by 
the CDC 
(https://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/Weighting/Task1_III.htm
). 
Since two survey cycles were combined in this study, fasting subsample weights 
(wtsaf2yr) were constructed using the NHANES formulae 
(https://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/Weighting/Task2.htm). 
Then, an analysis plan for complex samples was created in SPSS by specifying 
stratification and clustering variables (sdmvstra and sdmvpsu) as well as the sample 
weight statement. 
As normality of distribution was rejected, non-parametric tests were utilised. Missing 
values were treated by pairwise or test by test exclusion depending on the type of 
analysis. Statistical significance was assigned based on a p-value< 0.05. 
Spearman’s correlation test was used to check for the associations among obesity, 
insulin resistance, and lung function. To compare the effect of insulin resistance and 
visceral adiposity on pulmonary function test (PFT) parameters, a Mann-Whitney U 
test was performed. To investigate the effect of insulin resistance on PFT variables, 
a hierarchical multivariate multiple linear regression analysis was computed on 
models adjusted for age, sex, standing height, ethnicity (white vs. non-white), and 
smoking history. Predictive variables (BMI and HOMA-IR) were standardised using 
mean centring to counteract the effect of multicollinearity and to investigate the 
interactive effect of central adiposity and insulin resistance on pulmonary function. 
Then, predictors were compared for their unique contribution to the model. Finally, to 
examine the modifying effect of insulin resistance on the association between 
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adiposity and lung function, an adjusted multivariate multiple linear regression 
stratified by insulin sensitivity status was performed. This study was approved by 
London Metropolitan University ethics review panel. 
 
Results  
The main characteristics of the study population (n=1276) are presented in Table 1. 
In general, female participants had significantly lower PFT values but their BMI was 
significantly higher compared with their male counterparts (p<0.001). Overall, 
majority of participants were overweight and insulin resistant. Nonetheless, they had 
baseline FVC and FEV 1 recordings within the normal range. 
Table 1.  
 
As shown in Table 2, BMI, WC, and WHtR were all significant negative correlates of 
FVC, FEV1, and FEF 25-75% (p<0.001 for all). WHtR was the strongest 
anthropometric correlate of all PFT parameters. After stratification by gender, a 
similar pattern of association was observed between proxy measures of fatness 
(BMI, WC, and WHtR) and FVC as well as FEV 1 in both sexes. Again, WHtR was 
the measure which showed greatest correlation with FEV 1 and FVC in both sexes. 
With respect to FEF 25-75%, all anthropometric measures of adiposity exhibited 
statistically significant associations in men (p<0.001). In women, however, WC, and 
WHtR were the measures that reached statistical significance. HOMA-IR was 
negatively associated with FVC (r = -0.21 for men, and r = -0.24 for women, p<0.001, 
respectively) and FEV 1(r = -0.21 in men and r = -0.17 in women, p<0.001). In the 
analysis of all participants, insulin resistance was not associated with FEF 25-75%. 
 
Table2.  
 
As shown in Table 3, both insulin resistance and central obesity had significantly 
negative effects on FVC(p<0.001) and FEV1 (p<0.05) in both sexes. In contrast, FEF 
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25-75% was negatively affected by central obesity but not insulin sensitivity status 
(p<0.001).  
 
Table 3.  
 
Figure 1 illustrates the multivariate multiple linear regression analysis of the relations 
between PFT parameters and insulin resistance among all participants. This 
hierarchical model which also included age, sex, gender, smoking history, standing 
height, BMI, HOMA-IR and the BMI_HOMA-IR interaction as the fixed explanatory 
variables, could predict approximately 71% and 67% of the variances in FVC and 
FEV1 among adults with asthma, respectively (Figure 1). Height exhibited the 
highest contribution to the variation in FVC (standardised β= 0.41, p<0.001), followed 
by age (standardised β=-0.38, p<0.001). For FEV1, however, age was the greatest 
contributor (standardised β= -0.52, p<0.001), followed by height (standardised 
β=0.34, p<0.001). In this model, insulin resistance (defined by HOMA-IR≥ 2.5) was 
significantly associated with lower FVC and FEV1 (standardised β=-0.06 and -0.05, 
p<0.05), so that each unit increase in HOMA-IR was associated with approximately 
16 and 11 ml decrease in FVC and FEV1 values, respectively. Also, for each 
incremental point in BMI, FVC and FEV1 could drop by approximately 10 and 8 ml, 
respectively. Of interest, the association between IR and lung function was 
independent of BMI. As such, IR-BMI interaction made no statistically significant 
contribution to the model. Nevertheless, IR was not significantly associated with FEF 
25-75% in the regression model whereas BMI could predict 6% of the FEF 25-75% 
variance. 
 
Figure1 
 
Table 4 shows the estimated effect of adiposity measures on lung function, stratified 
by the insulin sensitivity status. BMI and WHtR (in separate models) contributed 
significantly to the prediction of FVC (p<0.01) and FEV 1 (p<0.05) in the insulin 
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resistant group, such that FVC decreased by approximately 14 ml for each point 
increment in BMI and by approximately 11 ml per 0.01 unit increase in WHtR. 
Correspondingly, FEV 1 declined by approximately 12 ml per unit increment in BMI 
and by 8 ml per 0.01 unit increment in WHtR. In contrast, the predictability of these 
adiposity measures for FVC and FEV 1 did not reach statistical significance in the 
insulin sensitive group.  
The standardised coefficients, semi-partial correlation coefficients and r-squared 
changes pertaining to these variables have been presented in table 4. 
The effect of IR on the relationship between central obesity and lung function in 
asthmatic adults is depicted in Figure 12. 
 
Table 4.  
 
Figure 12. 
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Discussion  
To the best of our knowledge, this is the first study to investigate the contribution of 
WHtR and insulin résistance to the quantitative estimation of the absolute spirometric 
indices PFT parameters (FEV1, FVC, and FEF25-75%) in asthmatic adults. Overall, 
an inverse relationship was found between adiposity measures and pulmonary 
function in both sexes. Of interest, WHtR was the strongest anthropometric correlate 
of all described PFT parameters. In keeping with these findings, the PLATINO study 
results have suggested a high WHtR as a predictor of low FVC in adults (Menezes et 
al. 2013). Previously, the greater discriminatory power of WHtR compared with WC 
and BMI had been established for the adverse cardiometabolic outcomes among 
adults of both sexes, indicating the importance of height and other undetermined 
factors in this relationship (Ashwell et al. 2012). In the present study, individuals with 
high WHtR had significantly lower PFT values as compared to those with WHtR in 
healthy range, reflecting the effect of centrally distributed body fat on the large as 
well as small airways. Obesity, particularly of central type (Ochs-Balcom 2006), 
affects pulmonary function both mechanically (Koenig 2001) and metabolically as 
reflected in lower values for FEV1 and FVC in overweight/obese adults (Chen et al 
2001). The inverse relationship between visceral adiposity and lung function could 
also be attributed to the low-grade systemic inflammation incited by adipokines in 
obesity (Rajala and Scherer 2003). Of note, IR in both sexes was negatively related 
to FVC and FEV1 but not FEF25–75%. FEF25-75 < 65% is suggested to be a 
specific predictor of bronchial responsiveness (Alberts et al. 1994) and a sensitive 
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marker for post-bronchodilator rise in FEV1 (Simon et al. 2010), known to be 
associated with poor asthma control (Rao et al. 2012). Moreover, low FEF25–75%, 
especially in the childhood, has been shown to predict poor asthma outcomes 
(Galant et al. 2011). 
Of importance, this study revealed that WHtR and IR could predict the impaired 
pulmonary function (with greater predictive ability for FVC than FEV1) in asthmatic 
adults independent of their age, height, sex, ethnicity, smoking history, and BMI. 
Furthermore, the interactive effect of IR and BMI did not have a significant 
contribution to the deterioration in lung function. Nonetheless, IR significantly 
modified the estimated effect of obesity measures on lung function, so that insulin 
resistant asthmatic adults with higher BMI and WHtR had lower FVC and FEV1 
compared to their more insulin-sensitive counterparts. These results concur with the 
findings of Forno et al. (2015), who reported a significant association of IR with FEV1 
and FVC among overweight/obese US adolescents, particularly those with asthma. 
However, they found a modifying effect for insulin resistance in a reverse direction. 
This inconsistency might be a result of differing effects of obesity and/or IR on lung 
function in children and adolescents versus adults, or the fact that BMI is not solely a 
measure of fat mass but a reflection of the growth process (Bekkers et al. 2015). In 
contrast, a case-control study on morbidly obese non-diabetic women indicated 
significantly negative correlations between HOMA-IR and PFT parameters (Lecube 
2010). Recently, Cardet et al. (2016) in an investigation of NHANES data, showed 
that IR strengthened the association of obesity and current asthma in adults by two 
folds, although they did not assess the contribution of IR to the association between 
visceral adiposity and PFT values. Nevertheless, in studies of free-living Korean 
males, the abdominal obesity (measured by WC) and IR (measured by) HOMA-IR 
were shown to be independent risk factors for reduced percentage of predicted (% 
pred) FVC and FEV1 (Lim et al 2010), as well as decreased absolute FVC (Kim et al. 
2010), even after adjusting for age, height, and metabolic components (Kim et al. 
2010). The interplay between asthma and IR in centrally obese individuals could be 
explained immunologically by the altered activation patterns of monocytes and T 
helper (Th) cells (Dixon et al. 2011; Rastogi et al. 2015), leading to the 
predominance of Th1 and M1 adipose tissue macrophages (Dekkers et al. 2009; 
Lumeng and Saltiel 2011; Gerriets and MacIver 2014). However, this study was not 
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able to evaluate this suggestion due to a lack to available biological data on 
components of the immune system. With regards to the nonsignificant contribution of 
IR-obesity interaction on impaired lung function, it could be argued that IR and the 
consequent hyperinsulinaemia may have both direct and independent effects on the 
proliferation and contractility of airway smooth muscle cells (Dekkers et al. 2009). 
Furthermore, it has been suggested that high insulin levels may also alter the 
diameter of small airways via central neuro-hormonal mechanisms (MacIver 2013).  
Further research is warranted in this area to identify those subtypes of asthma which 
are most affected by insulin resistance and to determine downstream pathways 
mediating lung-specific changes in centrally obese asthmatics with IR. 
This study was performed on a relatively large representative sample of US adults 
with reliable sets of data; data had been collected by uniformly trained personnel, in 
compliance with approved procedures and guidelines. It also included multiple 
anthropometric and spirometric measurements as well as indicators of insulin 
sensitivity. Statistically, the study gains from sample-weighted multivariate linear 
regression models analysing the absolute spirometric values instead of predicted 
PFT values, thereby facilitating the quantitative analysis of the insulin resistance 
contribution to pulmonary function. The models were adjusted for several 
confounders, including age, height and gender; this was further strengthened by 
choosing a hierarchical rather than a stepwise approach to find the best fitting model. 
The study also explored the effect of IR-obesity interaction on the lung function 
outcomes.  
There are, however, some limitations for this study. Since the sample population is 
selected from the NHANES database which is a cross-sectional study, causal 
relationship between insulin resistance and lung function cannot be determined. The 
inclusion criteria relied on a history of asthma rather than a strict objective method 
endorsed by the ATS, which may affect the accuracy of the results. Also, 
exacerbations and options used to manage asthma attacks in the past year were not 
taken into consideration. IR indicators derived from fasting glucose-insulin 
concentrations should also be interpreted cautiously when comparing mixed gender 
and mixed ethnicity populations because of their differing insulin secretion patterns 
and/or clearance which may confound the analysis. In addition, a number of factors 
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also contribute to the variability of lung function in asthmatics, including physical 
activity.  Estimates of physical activity in the NHANES database are based on the 
GPAQ - a subjective instrument which may not be a sufficiently accurate 
representation of the true activity levels in asthmatic adults. While the primary aim of 
this study was to investigate the main and interactive effects of anthropometric 
measures and insulin resistance on the parameters of pulmonary function in 
asthmatic adults, it was therefore decided not to include any PA variables in the 
regression model. Furthermore its inclusion could have caused a substantial rise in 
the number of missing values, leading to reduced statistical power and potentially 
misleading results. 
 
Conclusion  
This study elucidates that IR and increased WHtR are independent predictors of 
worsened pulmonary function in overweight/obese adults with asthma which modify 
the association between adiposity and lung physiology. Thus, central obesity and 
insulin resistance might synergistically increase asthma severity. This modifying 
effect could be an important factor contributing to asthma control and outcomes for 
asthmatic individuals.  
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Figure Legends 
 
 
 
Figure 1. Regression plots of the prediction models for lung function in asthmatic adults. The 
regression of baseline FVC(a) and FEV1 (b) values on a number of predicting variables, i.e., 
age, gender, ethnicity, smoking history, standing height, BMI, and HOMA-IR. 
 
 
 
Figure 2. The relationship between central obesity and lung function (FVC (a) and FEV1 (b)) 
values in asthmatic adults based on insulin sensitivity. 
 
 
 
